{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:49:31Z","timestamp":1792838971926,"version":"4.5.0"},"reference-count":54,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Women's Health"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:p>\n                    New U.S. Centers for Disease Control and Prevention (CDC) guidelines for hepatitis C virus (HCV) testing of perinatally exposed infants and children released in 2023 recommend a nucleic acid test (NAT) for detection of HCV ribonucleic acid (\n                    <jats:italic toggle=\"yes\">i.e.<\/jats:italic>\n                    , NAT for HCV RNA) at 2\u20136 months of age to facilitate early identification and linkage to care for children with perinatally acquired HCV infection. Untreated hepatitis C can lead to cirrhosis, liver cancer, and premature death and is caused by HCV, a blood-borne virus transmitted most often among adults through injection drug use in the United States. Perinatal exposure from a birth parent with HCV infection is the most frequent mode of HCV transmission among infants and children. New HCV infections have been increasing since 2010, with the highest rates of infection among people aged 20\u201339 years, leading to an increasing prevalence of HCV infection during pregnancy. In 2020, the CDC recommended one-time HCV screening for all adults aged 18 years and older and for all pregnant persons during each pregnancy. Detecting HCV infection during pregnancy is key for the identification of pregnant persons, linkage to care for postpartum treatment, and identification of infants with perinatal exposure for HCV testing. It was previously recommended that children who were exposed to HCV during pregnancy receive an antibody to HCV (anti-HCV) test at 18 months of age; however, most children were lost to follow-up before testing occurred, leaving children with perinatal infection undiagnosed. The new strategy of testing perinatally exposed children at age 2\u20136 months was found to be cost-effective in increasing the identification of infants who might develop chronic hepatitis C. This report describes the current perinatal HCV testing recommendations and how they advance national hepatitis C elimination efforts by improving the health of pregnant and postpartum people and their children.\n                  <\/jats:p>","DOI":"10.1089\/jwh.2023.1114","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T03:24:45Z","timestamp":1710300285000},"page":"695-701","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["CDC\u2019s New Hepatitis C Virus Testing Recommendations for Perinatally Exposed Infants and Children: A Step Towards Hepatitis C Elimination"],"prefix":"10.1177","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5216-0936","authenticated-orcid":false,"given":"Lakshmi","family":"Panagiotakopoulos","sequence":"first","affiliation":[{"name":"Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4672-4728","authenticated-orcid":false,"given":"Kathryn","family":"Miele","sequence":"additional","affiliation":[{"name":"Division of Birth Defects and Infant Disorders, Centers for Disease Control and Prevention, Atlanta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Cartwright","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleem","family":"Kamili","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Woodworth","sequence":"additional","affiliation":[{"name":"Division of Birth Defects and Infant Disorders, Centers for Disease Control and Prevention, Atlanta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van T.","family":"Tong","sequence":"additional","affiliation":[{"name":"Division of Birth Defects and Infant Disorders, Centers for Disease Control and Prevention, Atlanta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Y.","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Birth Defects and Infant Disorders, Centers for Disease Control and Prevention, Atlanta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Wester","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Sandul","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32129"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/27.4.574"},{"issue":"11","key":"e_1_3_6_4_1","first-page":"1351","article-title":"Hepatitis C: Diagnosis and treatment","volume":"81","author":"Wilkins T","year":"2010","unstructured":"3. Wilkins T, , Malcolm JK, , Raina D, et al. Hepatitis C: Diagnosis and treatment. Am Fam Physician, 2010; 81(11):1351\u20131357.","journal-title":"Am Fam Physician"},{"key":"e_1_3_6_5_1","volume-title":"Division of Viral Hepatitis 2025 Strategic Plan","author":"Centers for Disease Control and Prevention","year":"2020","unstructured":"4. Centers for Disease Control and Prevention. Division of Viral Hepatitis 2025 Strategic Plan. CDC; 2020."},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.3692"},{"key":"e_1_3_6_7_1","unstructured":"6. World Health Organization. Interim guidance for country validation of viral hepatitis elimination. 2021."},{"key":"e_1_3_6_8_1","unstructured":"7. Centers for Disease Control and Prevention. 2021 viral hepatitis surveillance report. 2023. Available from: https:\/\/www.cdc.gov\/hepatitis\/statistics\/2021surveillance\/index.htm [Last accessed: September15]."},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7006a4"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0855-y"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2017.304132"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2018.05.029"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005119"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:124659"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6902a1"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0000000000004822"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu447"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac270"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw026"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2018.1458836"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0000000000002757"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-2482"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7204a1"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2350"},{"issue":"4","key":"e_1_3_6_25_1","first-page":"1","article-title":"Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C","volume":"40","author":"Centers for Disease Control and Prevention Food and Drug Administration and National Institutes of Health","year":"1991","unstructured":"24. Centers for Disease Control and Prevention Food and Drug Administration and National Institutes of Health. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR Recomm Rep, 1991; 40(RR-4):1\u201317.","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"e_1_3_6_26_1","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945\u20131965","volume":"61","author":"Smith BD","year":"2012","unstructured":"25. Smith BD, , Morgan RL, , Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945\u20131965. MMWR Recomm Rep, 2012; 61(RR-4):1\u201332.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1123"},{"key":"e_1_3_6_28_1","unstructured":"27. AASLD-IDSA. HCV in pregnancy. Available from: https:\/\/www.hcvguidelines.org\/unique-populations\/pregnancy [Last accessed: June2]."},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005300"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.06.008"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-020-03106-y"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004980"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(20)30062-8"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00168-6"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1086\/497701"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005306"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1086\/430601"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1086\/315264"},{"issue":"09","key":"e_1_3_6_39_1","article-title":"Spontaneous clearance of vertically acquired hepatitis C infection: Implications for testing and treatment","volume":"09","author":"Ades AE","year":"2022","unstructured":"38. Ades AE, , Gordon F, , Scott K, et al. Spontaneous clearance of vertically acquired hepatitis C infection: Implications for testing and treatment. Clin Infect Dis, 2022; 09(09).","journal-title":"Clin Infect Dis"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac255"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26519"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.11.037"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22094"},{"key":"e_1_3_6_44_1","unstructured":"43. AASLD-IDSA. HCV in children. Available from: https:\/\/www.hcvguidelines.org\/unique-populations\/children [Last accessed: June2]."},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002814"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1542\/9781610025225"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-4019"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-1275"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa949"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2023.113409"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7228a2"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004760"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2022.02.002"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2020.05.003"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac225"}],"container-title":["Journal of Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jwh.2023.1114","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2023.1114","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2023.1114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:00:47Z","timestamp":1777658447000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/jwh.2023.1114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1089\/jwh.2023.1114"],"URL":"https:\/\/doi.org\/10.1089\/jwh.2023.1114","relation":{},"ISSN":["1540-9996","1931-843X"],"issn-type":[{"value":"1540-9996","type":"print"},{"value":"1931-843X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}